Results 121 to 130 of about 39,566 (236)

Disseminated Chronic Tophaceous Gout With Multi‐Tissue Involvement

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Gout is a metabolic condition in which hyperuricaemia leads to deposition of monosodium urate (MSU) crystals in synovial and peri‐articular tissues. (1) Acutely, synovial deposition causes a painful inflammatory reaction. Over time, chronic hyperuricaemia can lead to deposition of uric acid crystals in alternate tissues, with granulomatous ...
Yee Leng Loh, Fiona Combe
wiley   +1 more source

Streamlining the MRI-Derived Vertebral Bone Quality Score for Preoperative Osteoporosis and Osteopenia Screening. [PDF]

open access: yesGlobal Spine J
Köhli P   +18 more
europepmc   +1 more source

Alpha‐Mannosidosis in a 3.5‐Year‐Old Girl: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Alpha‐mannosidosis is a rare lysosomal storage disease caused by a deficiency of the enzyme alpha‐mannosidase. It manifests as a continuous spectrum of signs and symptoms characterized by dysmorphic features, skeletal abnormalities, delayed psychomotor and speech development, impaired hearing, and psychiatric involvement. When suspected, alpha‐
Samuel Bonilla Fornes   +4 more
wiley   +1 more source

Calcaneal quantitative ultrasound parameters strongly correlate with DXA measurements in patients with acromegaly. [PDF]

open access: yesPituitary
Campana C   +11 more
europepmc   +1 more source

A Diagnostic Dilemma: Hypophosphatemic Rickets Unmasking Tyrosinemia Type 1: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT A 7.5‐year‐old Pakistani girl was misdiagnosed with hypophosphatemic rickets. Progressive skeletal deformities, hepatomegaly, and renal tubular dysfunction were detected despite standard treatment. Due to the atypical findings, genetic testing was performed and confirmed the diagnosis of Hereditary tyrosinemia Type 1.
Muhammad Wajid Siddique   +5 more
wiley   +1 more source

Discontinuing Long‐Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 334-344, August 2026.
Discontinuation of denosumab (Dmab) may be necessary due to adverse events or an unfavorable long‐term risk–benefit profile. However, accumulating evidence demonstrates pronounced rebound phenomena after withdrawal, most notably a marked increase in multiple vertebral fractures, and, in some reports, elevated mortality.
Ko‐Hsiu Lu   +5 more
wiley   +1 more source

The interplay between osteosarcopenia and intrinsic capacity: insights and associations with all-cause mortality in the Toledo Study for Healthy Aging. [PDF]

open access: yesJ Gerontol A Biol Sci Med Sci
Baltasar-Fernandez I   +36 more
europepmc   +1 more source

Comparative Diagnostic Performance of Cone Beam Computed Tomography and Dual‐Energy X‐Ray Absorptiometry for Low Bone Density Assessment. A Systematic Review and Meta‐Analysis

open access: yesClinical and Experimental Dental Research, Volume 12, Issue 4, August 2026.
ABSTRACT Objective This systematic review evaluated the diagnostic accuracy of CBCT for BMD assessment using DEXA as the reference standard and aimed to quantify its performance through meta‐analysis. Materials and Methods This review included prospective and retrospective observational studies assessing CBCT's diagnostic performance in detecting low ...
Mohammad Alrashidi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy